DMS1 Stock Overview
Operates in the medical imaging industry in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Diagnostic Medical Systems S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.82 |
| 52 Week High | €1.32 |
| 52 Week Low | €0.77 |
| Beta | 0.96 |
| 11 Month Change | -11.61% |
| 3 Month Change | -20.19% |
| 1 Year Change | -35.53% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| DMS1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.9% | -3.5% | 0.8% |
| 1Y | -35.5% | 2.2% | 6.1% |
Return vs Industry: DMS1 underperformed the German Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: DMS1 underperformed the German Market which returned 6.1% over the past year.
Price Volatility
| DMS1 volatility | |
|---|---|
| DMS1 Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 4.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: DMS1's share price has been volatile over the past 3 months.
Volatility Over Time: DMS1's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 120 | Samuel Sancerni | www.dms.com |
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France and internationally. The company offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, and mobile C-arms solutions. It also provides technologies for the treatment of osteoarthritis, and regenerative medicine based on the injection of fat stem cells.
Diagnostic Medical Systems S.A. Fundamentals Summary
| DMS1 fundamental statistics | |
|---|---|
| Market cap | €16.76m |
| Earnings (TTM) | -€9.80m |
| Revenue (TTM) | €42.20m |
0.4x
P/S Ratio-1.7x
P/E RatioIs DMS1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMS1 income statement (TTM) | |
|---|---|
| Revenue | €42.20m |
| Cost of Revenue | €0 |
| Gross Profit | €42.20m |
| Other Expenses | €52.00m |
| Earnings | -€9.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 100.00% |
| Net Profit Margin | -23.22% |
| Debt/Equity Ratio | 76.1% |
How did DMS1 perform over the long term?
See historical performance and comparison